89 results
Page 2 of 5
424B5
fz3z39rglug 6naljqi
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
h2e6c xt4i
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K/A
EX-99.1
4tc1r2br65wc8sw 8yk
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
2mv7hh5krn
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.3
ydghu0 2fzv
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-10.3
5u5e1axi9tufq9i3
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
qam7z 52tp50tz8fy
28 Aug 20
Prospectus supplement
4:31pm
425
y2354dgt ma5
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
u6p783h9rlqs enahh
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
DEFA14A
ubal271x352kts n5kor
29 Apr 20
Additional proxy soliciting materials
4:05pm
S-3ASR
4lygnah0vom
20 Apr 20
Automatic shelf registration
4:59pm